ABSTRACT
For the past years, human-based ADME-tox systems have been developed for the evaluation of human-specific drug properties. Recently, these systems have been applied early in the drug discovery phase to aid the selection of lead molecules for further development. In general, the assays are used to optimize for intestinal absorption, metabolic stability, toxicity, and drug-drug interaction potential.
